NCT05174923

Brief Summary

Variability of physical assessments in an older population that is overweight or obese.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
58

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2021

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 20, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 5, 2021

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 5, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 5, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 3, 2022

Completed
Last Updated

January 3, 2022

Status Verified

December 1, 2021

Enrollment Period

2 months

First QC Date

November 5, 2021

Last Update Submit

December 13, 2021

Conditions

Outcome Measures

Primary Outcomes (6)

  • To assess the variability of Short Physical Performance Battery (SPPB, scored from 0-12) results within and between participants.

    Baseline (+7 day window)

  • To assess the variability of the 30 Second Chair Stand (30CST) results within and between participants.

    Baseline (+7 day window)

  • To assess the variability of grip strength results (kg) with the use of a hand grip dynamometer within and between participants.

    Baseline (+7 day window)

  • To assess the variability of the individual Short Physical Performance Battery (SPPB) with subsets (subsets of Balance, Gait and Chair Stand scored 0-4) within participants.

    Baseline (+7 day window)

  • To compare the variability between the 5 Repetition Sit to Stand (5STS) subtest of the SPPB and 30CST.

    Baseline (+7 day window)

  • To assess the correlation between bioelectrical impedance analysis (BIA) and waist circumference (WC) as well as body mass index (BMI).

    Baseline (+7 day window)

Study Arms (3)

Age Range 45 to </= 60

Behavioral: Short Performance Physical Battery (SPPB Test)Behavioral: 30 Second Chair Stand Test (30CST)Behavioral: Hand grip dynamometry

Age Range 61 to </= 75

Behavioral: Short Performance Physical Battery (SPPB Test)Behavioral: 30 Second Chair Stand Test (30CST)Behavioral: Hand grip dynamometry

Age >/= 76

Behavioral: Short Performance Physical Battery (SPPB Test)Behavioral: 30 Second Chair Stand Test (30CST)Behavioral: Hand grip dynamometry

Interventions

The SPPB includes balance stands, a 4-meter walk and 5 timed chair stands.

Age >/= 76Age Range 45 to </= 60Age Range 61 to </= 75

The 30CST measures the number of times a person can rise from a seated to standing position within 30 seconds.

Age >/= 76Age Range 45 to </= 60Age Range 61 to </= 75

Grip strength is used as a marker of overall muscle strength.

Age >/= 76Age Range 45 to </= 60Age Range 61 to </= 75

Eligibility Criteria

Age45 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Approximately 60 male and female participants 45 years of age or older who are overweight or obese will be enrolled. To ensure data are collected from a wide age range, 20 participants will be enrolled per specified age ranges. The study population must include at least 40% females in the overall study.

You may qualify if:

  • A written informed consent must be obtained before any study-related assessment is conducted.
  • Men and women aged ≥ 45.
  • BMI ≥ 30 or BMI ≥ 27 with one or more obesity-associated comorbidities (e.g. hypertension, cardiovascular disease, hyperlipidemia, elevated fasting blood sugar levels, sleep apnea).
  • Participants must be able to communicate well with the Investigator and comply with the study requirements.

You may not qualify if:

  • Participant weight \> 150 kg.
  • Systolic blood pressure \< 90 or \> 180 or diastolic blood pressure \<50 or \>100.
  • Heart rate ≤ 50 or ≥ 100.
  • Unstable medical condition that would put the participant at risk by performing the study assessments.
  • Chronic medical condition rendering participants unable to perform the assessment, e.g., severe knee osteoarthritis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

CNS Healthcare

Jacksonville, Florida, 32256, United States

Location

CNS Healthcare

Orlando, Florida, 32801, United States

Location

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 5, 2021

First Posted

January 3, 2022

Study Start

September 20, 2021

Primary Completion

November 5, 2021

Study Completion

November 5, 2021

Last Updated

January 3, 2022

Record last verified: 2021-12

Data Sharing

IPD Sharing
Will not share

Locations